Size-dependent increase in prostanoid levels in adenomas of patients with familial adenomatous polyposis

Cancer Research

Volumn 58, Issue 8, 1998, Pages 1750-1753

  Yang, Vincent W ^a   Shields, Janiel M ^a   Hamilton, Stanley R ^a   Spannhake, Ernst W ^b   Hubbard, Walter C ^a   Hylind, Linda M ^a   Robinson, C Rahj ^a   Giardiello, Francis M ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 OXOPROSTAGLANDIN F1 ALPHA; ARACHIDONIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN SYNTHASE INHIBITOR; PROSTANOID; THROMBOXANE B2;

ADENOMATOUS POLYP; ADULT; ARACHIDONIC ACID METABOLISM; ARTICLE; CANCER PREVENTION; CLINICAL ARTICLE; COLON CARCINOGENESIS; COLON MUCOSA; COLON POLYP; COLORECTAL CANCER; DRUG EFFECT; FAMILIAL DISEASE; FEMALE; HUMAN; MALE; PRIORITY JOURNAL;

6-KETOPROSTAGLANDIN F1 ALPHA; ADENOMA; ADENOMATOUS POLYPOSIS COLI; ADULT; DINOPROST; DINOPROSTONE; FEMALE; HUMANS; INTESTINAL MUCOSA; MALE; OXYTOCICS; PROSTAGLANDIN D2; PROSTAGLANDINS; THROMBOXANE B2;

EID: 0032522616     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Giardiello, F. M., Offerhaus, G. J. A., and DuBois, R. N. The role of nonsterodial anti-inflammatory drugs in colorectal cancer prevention. Eur. J. Cancer, 31A: 1071-1076, 1995.
2. DuBois R. N., and Smalley, W. E. Cyclooxygenases, NSAIDs, and colorectal cancer. J. Gastroenterol., 31. 898-906, 1996.
3. Levy, G. N. Prostaglandin H synthases, nonsteroidal anti-inflammatory drugs, and colon cancer. FASEB J., 11: 234-247, 1997.
4. Pollard, M., and Luckert, P. H. Indomethacin treatment of rats of dimethylhydrazine-induced intestinal tumors. Cancer Treat. Rep., 64: 1323-1327, 1980.
5. Moorghen, M., Ince, P., Finney, K. J., Sunter, J. P., Appleton, D. R., and Watson, A. J. A protective effect of sulindac against chemically-induced primary colonic tumors in mice. J. Pathol., 156: 341-347, 1988.
6. Reddy, B. S., Rao, C. V., Rivenson, A., and Kelloff, G. Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats. Carcinogenesis (Lond.), 14: 1493-1497, 1993.
7. Thun, M. J., Namboodiri, M. M., and Heath, C. W. Aspirin use and reduced risk of fatal colon cancer. N. Engl. J. Med., 325: 1593-1596, 1991.
8. Thun, M. J., Namboodiri, M. M., Calle, E. E., Flanders, W. D., and Heath, C. W. Aspirin use and risk of fatal cancer. Cancer Res., 53: 1322-1327, 1993.
9. Giardiello, F. M., Hamilton, S. R., Krush, A. J., Piantadosi, S., Hylind, L. M., Celano, P., Booker, S. V., Robinson, C. R., and Offerhaus, G. J. A. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N. Engl. J. Med., 398: 1313-1316, 1993.
10. Labayle, D., Fischer, D., Vielh, P., Drouhin, F., Pariente, A., Bories, C., Duhamel, O., Trousset, M., and Attali, P. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology, 101: 635-639, 1991.
11. Nugent, K. P., Farmer, K. C. R., Spigelman, A. D., Williams, C. B., and Phillips, R. K. S. Randomized controlled clinical trial of sulindac on intestinal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br. J. Surg., 80: 1618-1619, 1993.
12. Beazer-Barclay, Y., Levy, D. B., Moser, A. R., Dove, W. F., Hamilton, S. R., Vogelstein, B., and Kinzler, K. W. Sulindac suppresses tumorigenesis in the Min mouse. Carcinogenesis (Lond.), 17: 1757-1760, 1996.
13. Min mouse model by the nonsteroidal anti-inflammatory drug piroxicam. Cancer Res., 56: 710-714, 1996.
14. Boolbol, S. K., Dannenberg, A. J., Chadburn, A., Martucci, C., Guo, X. J., Ramonetti, J. T., Abreu-Goris, M., Newmark, H. L., Lipkin, M. L., DeCosse, J. J., and Beragnolli, M. M. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis. Cancer Res., 56: 2556-2560, 1996.
15. Williams, C. S., and DuBois, R. N. Prostaglandin endoperoxide synthase: why two isoforms? Am. J. Physiol., 270: G393-G400, 1996.
16. Herschman, H. R. Regulation of prostaglandin synthase-1 and prostaglandin synthase-2. Cancer Metastasis Rev., 13: 241-256, 1994.
17. Marnett, L. J. Aspirin and the potential role of prostaglandins in colon cancer. Cancer Res., 52: 5575-5589, 1992.
18. Smith, W. L. Prostanoid biosynthesis and mechanisms of action. Am. J. Physiol., 263: F181-F191, 1992.
19. Tanka, M., Nazkazawa, S., and Kiike, M. Investigation of endogenous prostaglandin in DMH-induced colonic cancer in rats. J. Gastroenterol., 82: 592-598, 1985.
20. Yamaguchi, A., Ishida, T., Nishimura, G., Katoh, M., and Miyazaki, I. Investigation of colonic prostaglandin in carcinogenesis in the rat colon. Dis. Colon Rectum, 34: 572-576, 1991.
21. 2. Gut, 35: 675-678, 1994.
22. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 122: 518-523, 1993.
23. Nugent, K. P., Spigelman, A. D., and Phillips, R. K. S. Tissue prostaglandin levels in familial adenomatous polyposis patients treated with sulindac. Dis. Colon Rectum, 39: 659-662, 1996.
24. Winde, G., Schmid, K. W., Schlegel, W., Fischer, R., Osswald, H., and Bunte, H. Complete reversion and prevention of rectal adenomas in colectomized patients with familial adenomatous polyposis by rectal low-dose sulindac maintenance treatment. Dis. Colon Rectum, 38: 813-830, 1995.
25. Giardiełlo, F. M., Spannhake, E. W., DuBois, R. N., Hylind, L. M., Robinson, C. R., Hubbard, W. C., Hamilton, S. R., and Yang, V. W. Prostaglandin levels in human colorectal mucosa: effects of sulindac in patients with familial adenomatous polyposis. Dig. Dis. Sci., 43: 311-316, 1998.
26. Griswold, D. E., and Adams, J. L. Constitutive cyclooxygenase (COX-1) and inducible cyclooxygenase (COX-2): rationale for selective inhibition and progress to date. Med. Res. Rev., 16: 181-206, 1996.
27. Hubbard, W. C., Litterst, C. L., Liu, M. C., Bleecker, E. R., Eggleston, J. C., McLemore, T. L., and Boyd, M. R. Profiling of prostaglandin biosynthesis in biopsy fragments of human lung carcinomas and normal human lung by capillary gas chromatography-negative ion chemical ionization mass spectrometry. Prostaglandins, 32: 889-906, 1986.
28. Kargman, S., Charleson, S., Cartwright, M., Frank, J., Reideau, D., Mancini J., Evans, J., and O'Neill, G. Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey, and human gastrointestinal tracts. Gastroenterology, 111: 445-454, 1996.
29. Kinzler, K. W., and Vogelstein, B. Lessons from hereditary colorectal cancer. Cell, 87: 159-170, 1996.
30. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and DuBois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107: 1183-1188, 1994.
31. Sano, H., Kawahito, Y., Wilder, R. L., Hashiramoto, A., Mukai, S., Asai, K., Kimura, S., Kato, H., Kondo, M., and Hla, T. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res., 55: 3785-3789, 1995.
32. Williams, C. S., Luongo, C., Radhika, A., Zhang, T., Lamps, L. W., Nanney, L. B., Beauchamp, R. D., and DuBois, R. N. Elevated cyclooxygenase-2 levels in Min mouse adenomas. Gastroenterology, 111: 1134-1140, 1996.
33. DuBois, R. N., Radhika, A., Reddy, B. S., and Entingh, A. J. Increased cyclooxygenase-2 levels in carcinogen-induced rat colonic tumors. Gastroenterology, 110: 1259-1262, 1996.
34. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell, 87: 803-809, 1996.
35. Prescott, S. M., and White, R. L. Self-promotion? Intimate connections between APC and prostaglandin H synthase-2. Cell, 87: 783-786, 1996.
36. Thompson, H. J., Briggs, S., Paranka, N. S., Piazza, G. A., Brendel, K., Gross, P. H., Sperl, G. J., Pamukcu, R., and Ahnen, D. J. Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac. J. Natl. Cancer Inst., 87: 1259-1260, 1995.
37. Alberts, D. S., Hixson, L., Ahnen, D., Bogert, C., Einspahr, J., Paranka, N., Brendel, K., Gross, P. H., Pamukcu, R., and Burt, R. W. Do NSAIDs exert their colon cancer chemopreventive activities through the inhibition of mucosal prostaglandin synthetase? J. Cell. Biochem. Suppl., 22: 18-23, 1995.